NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, today announced the hiring of William Tanner as a Managing Director and senior biotech research analyst.
Mr. Tanner will start work at Guggenheim in May 2015 in the firm’s New York office.
“Bill brings a wealth of biotech experience, in both investment and academic research, to our experienced and highly acclaimed healthcare team,” said Matthew Johnson, Senior Managing Director and Head of Equities at Guggenheim Securities. “Bill will join a healthcare research team that includes, on the equities side, Tony Butler in biopharmaceuticals and Louise Chen in specialty pharmaceuticals, and, on the government policy side, Rick Weissenstein in healthcare policy analysis in Washington.”
“Bill’s hiring is part of a highly-focused recent expansion of our research capabilities in such key sectors as tech-media-telecom, consumer, energy, and financial services,” said John Hervey, Senior Managing Director and Director of Research at Guggenheim Securities. “The goal is to continue to enhance our ability to help our clients achieve outstanding investment results.”
Mr. Tanner has worked nearly 20 years as a biotech analyst, including senior analyst roles at Leerink Swann and SG Cowen.
He holds a Bachelor of Science degree and a PhD in Physiology, both from Texas A&M University, as well as an MBA from Washington University’s Olin School of Business. Before embarking on his investment research career, Mr. Tanner worked as a post-doctoral research fellow at Monsanto Co. and as an NIH National Research Service Award fellow at Washington University School of Medicine.
Guggenheim Partners is a global investment and advisory firm with more than $220 billion in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.
NEW YORK, NY – April 24, 2023 -- Guggenheim Securities, the investment banking and capital mar...
NEW YORK, NY – April 20, 2023 — Guggenheim Securities, the investment banking and capita...
NEW YORK, NY – March 30, 2023 — Guggenheim Securities, the investment banking and capita...